Recent advances in the treatment and outcome of locally advanced rectal cancer

被引:46
|
作者
Vauthey, JN
Marsh, RD
Zlotecki, RA
Abdalla, EK
Solorzano, CC
Bray, EJ
Freeman, ME
Lauwers, GY
Kubilis, PS
Mendenhall, WM
Copeland, EM
机构
[1] Univ Florida, Coll Med, Dept Surg, Gainesville, FL USA
[2] Univ Florida, Coll Med, Dept Med, Div Hematol Oncol, Gainesville, FL USA
[3] Univ Florida, Coll Med, Dept Radiat Therapy, Gainesville, FL USA
[4] Univ Florida, Coll Med, Dept Pathol, Gainesville, FL USA
[5] Univ Florida, Coll Liberal Arts & Sci, Dept Stat, Div Biostat, Gainesville, FL USA
关键词
D O I
10.1097/00000658-199905000-00018
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective To compare the outcomes of treatment of locally advanced rectal cancer of the early era (1975-1990) with those of the late era (1991-1997). Background Preoperative therapy has been used in locally advanced rectal cancer to preserve sphincter function, decrease local recurrence, and improve survival. At the University of Florida, preoperative radiation has been used since 1975, and it was combined with chemotherapy beginning in 1991. Methods The records of 328 patients who underwent preoperative radiation or chemoradiation followed by complete resection for locally advanced rectal cancer defined as tethered, annular, or fixed tumors were reviewed. The clinicopathologic characteristics, adjuvant treatment administered, surgical procedures performed, and local recurrence-free and overall survival rates were analyzed. Results There were 219 patients in the early era and 109 in the late era. No significant differences were seen in patients (age, gender, race) or tumor characteristics (mean distance from the anal verge, annularity, fixation). Preoperative radiation regimens were radiobiologically comparable. No patient in the early era received preoperative chemotherapy, compared with 64 in the late era. Of those receiving any pre- or postoperative chemotherapy, three patients received chemotherapy in the early era, compared with 76 in the late era. Sphincter-preserving procedures increased from 13% in the early era to 52% in the late era. Pathologic downstaging for depth of invasion increased from 42% to 58%, but lymph node negativity remained similar. The 1-, 3-, and 5-year local recurrence-free survival rates were comparable. However, in the late era, 1-, 3-, and 5-year overall survival rates improved significantly compared with those of the early era, and also compared with each of the preceding 5-year intervals. Conclusion The addition of a chemotherapy regimen to preoperative radiation therapy improves survival over radiation therapy alone. Likewise, an improvement in downstaging is associated with an increase iii sphincter-preserving procedures.
引用
收藏
页码:745 / 754
页数:10
相关论文
共 50 条
  • [1] Advances in the treatment of locally advanced rectal cancer
    Ali, Fadwa
    Keshinro, Ajaratu
    Wesiser, Martin R.
    [J]. ANNALS OF GASTROENTEROLOGICAL SURGERY, 2021, 5 (01): : 32 - 38
  • [2] Advances and Challenges in Treatment of Locally Advanced Rectal Cancer
    Smith, J. Joshua
    Garcia-Aguilar, Julio
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (16) : 1797 - +
  • [3] Recent Advances in Functional MRI to Predict Treatment Response for Locally Advanced Rectal Cancer
    Gao, Yu
    Pham, Jonathan
    Yoon, Stephanie
    Cao, Minsong
    Hu, Peng
    Yang, Yingli
    [J]. CURRENT COLORECTAL CANCER REPORTS, 2021, 17 (06) : 77 - 87
  • [4] Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Recent Advances and Ongoing Challenges
    Body, Amy
    Prenen, Hans
    Lam, Marissa
    Davies, Amy
    Tipping-Smith, Samuel
    Lum, Caroline
    Liow, Elizabeth
    Segelov, Eva
    [J]. CLINICAL COLORECTAL CANCER, 2021, 20 (01) : 29 - 41
  • [5] Advances in surgery for locally advanced rectal cancer
    Oh, Bo Young
    [J]. ANNALS OF COLOPROCTOLOGY, 2022, 38 (04) : 279 - 280
  • [6] Minimally invasive surgery for locally advanced rectal cancer: recent advances and future developments
    Peterson, Carrie Y.
    Weiser, Martin R.
    [J]. COLORECTAL CANCER, 2013, 2 (02) : 155 - 164
  • [7] Treatment of locally advanced rectal cancer
    Klaassen, RA
    Nieuwenhuijzen, GAP
    Martijn, H
    Rutten, HJT
    Hospers, GAP
    Wiggers, T
    [J]. SURGICAL ONCOLOGY-OXFORD, 2004, 13 (2-3): : 137 - 147
  • [8] Recent Advances in Combined Modality Treatment for Locally Advanced Pancreatic Cancer
    Aksu, Gorkem
    Sarper, Binnaz
    Ulutin, Cuneyt
    Bakkal, Hakan
    [J]. CURRENT CANCER THERAPY REVIEWS, 2005, 1 (03) : 227 - 237
  • [9] Pathologic response to neoadjuvant treatment in locally advanced rectal cancer and impact on outcome
    Jalilian, Mahshid
    Davis, Sidney
    Mohebbi, Mohammadreza
    Sugamaran, Bhuvana
    Porter, Ian W.
    Bell, Stephen
    Warrier, Satish K.
    Wale, Roger
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2016, 7 (04) : 603 - 608
  • [10] Outcome after the introduction of a multimodality treatment program for locally advanced rectal cancer
    Palmer, G
    Martling, A
    Blomqvist, L
    Cedermark, B
    Holm, T
    [J]. EJSO, 2005, 31 (07): : 727 - 734